Helio Corp Finalizes Reverse Stock Split for Nasdaq Uplisting and Public Offering
Summary
Helio Corp has filed a definitive information statement confirming the approval of a reverse stock split (1.25-for-1 to 5-for-1) to enable its uplisting to the Nasdaq Capital Market and a related public offering. This action is crucial for the company's financial stability and future capital access.
Key Events
-
Reverse Stock Split Approved
The Board of Directors and majority shareholders approved a reverse stock split at a ratio between 1.25-for-1 and 5-for-1, with the exact ratio and timing to be determined by the Board within 12 months.
-
Purpose: Nasdaq Uplisting and Public Offering
The reverse stock split is intended to meet Nasdaq Capital Market listing requirements and facilitate a related underwritten public offering, a critical step for future financing.
-
Definitive Information Statement Filed
This DEF 14C formally notifies shareholders of the approved action, initiating a 20-calendar day waiting period before the reverse stock split can become effective.
-
Shareholder Consent Details
Majority shareholders, including CEO Edward Cabrera (11.84%), CTO Gregory Delory (22.10%), and Chief Engineer Paul Turin (30.50%), provided written consent for the action on May 11, 2026.
Analysis
This definitive filing confirms the previously announced reverse stock split, a critical step for Helio Corp to address its 'going concern' issues and secure future financing. The ability to uplist to Nasdaq and conduct a public offering could provide essential capital and improve liquidity, but it also carries the risk that the market price may not sustain the post-split level. The 20-day waiting period before the split can become effective begins with this filing.
At the time of this filing, HLEO was trading at $3.62 on OTC in the Manufacturing sector, with a market capitalization of approximately $91.7M. The 52-week trading range was $0.10 to $9.80. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.